Metronomic Chemo-Endocrine Therapy (FulVEC) as a Salvage Treatment for Patients with Advanced, Treatment-Refractory ER+/HER2-Breast Cancer—A Retrospective Analysis of Consecutive Patients Data

Background: Breast cancer, with 2.3 million new cases and 0.7 million deaths every year, represents a great medical challenge worldwide. These numbers confirm that approx. 30% of BC patients will develop an incurable disease requiring life-long, palliative systemic treatment. Endocrine treatment and...

Descripción completa

Detalles Bibliográficos
Autores principales: Buda-Nowak, Anna, Kwinta, Łukasz, Potocki, Paweł, Michałowska-Kaczmarczyk, Anna, Słowik, Agnieszka, Konopka, Kamil, Streb, Joanna, Koniewski, Maciej, Wysocki, Piotr J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958758/
https://www.ncbi.nlm.nih.gov/pubmed/36835886
http://dx.doi.org/10.3390/jcm12041350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958758/
https://www.ncbi.nlm.nih.gov/pubmed/36835886
http://dx.doi.org/10.3390/jcm12041350

Ejemplares similares